Source: Pharmaceutical Business Review
Posted: July 5, 2006
Summary:
Scientists at the University of Florida's McKnight Brain Institute conducting research with embryonic stem cells from mice have announced findings that may eventually enable scientists to create laboratory environments that will allow them to grow specialized cells that can be transplanted into patients with brain disorders such as epilepsy, Parkinson's and Alzheimer's.
Commentary: Maybe this finding will enable scientists to create cells that will be able to be safely administered to patients and treat disease without posing risks of immune system rejection or other harmful side effects.
No comments:
Post a Comment